Latest 30 News in the Life Sciences Industry
GlobeNewswire
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
17 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
GlobeNewswire
Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
07 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
GlobeNewswire
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
30 Apr 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
GlobeNewswire
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29 Apr 2026
GlobeNewswire
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
28 Apr 2026
GlobeNewswire
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
27 Apr 2026
GlobeNewswire
A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
24 Apr 2026
GlobeNewswire
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24 Apr 2026
GlobeNewswire
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
24 Apr 2026
GlobeNewswire
DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration
24 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
29 Mar 2026
PR Newswire Association LLC.
Apollo Hospitals Brings Advanced Super Speciality Care to the Heart of Mumbai with New Centre in Dadar
13 May 2026
PR Newswire Association LLC.
Apollo Hospitals introduces first of its kind advanced bone regeneration solution for diabetic and complex bone infections
05 May 2026
PR Newswire Association LLC.
Syngene strengthens leadership team with two key appointments
04 May 2026
PR Newswire Association LLC.
From South America to South India: A Young Life Stands Tall Again After Complex Robotic Spine Surgery
23 Apr 2026
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
PR Newswire Association LLC.
Apollo Hospitals Enhances its Air Ambulance Services, Faster Access to Critical Care in India and Abroad
02 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
27 Mar 2026
PR Newswire Association LLC.
NIPER Raebareli partners with Roche Pharma to Strengthen Pharmaceutical Education and Research Capability Building Collaboration
19 Mar 2026
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day